Core Insights - NNIT has made strategic progress in 2025, improving operational efficiency and refining its go-to-market approach, but faced financial challenges due to a difficult macroeconomic environment and geopolitical uncertainty, particularly in Europe [1] - The US region experienced a temporary slowdown in business performance towards the end of 2025, affecting growth and profitability [1] Financial Performance - For the full year 2025, NNIT reported revenue of DKK 1,788 million, reflecting a reported revenue growth of -3.4% and organic growth of -2.8% [8] - Group operating profit excluding special items was DKK 94 million, down from DKK 117 million in 2024, resulting in a margin of 5.3% compared to 6.3% in 2024 [8] - Special items amounted to DKK 83 million, primarily due to restructuring costs and strategic projects [8] Financial Outlook for 2026 - NNIT anticipates constant currency revenue growth to be between 0% to 5% in 2026, with a group EBIT margin excluding special items expected to range from 6% to 9% [9] - Special items are expected to be significantly lower than the previous year's level of DKK 83 million, mainly consisting of restructuring costs [9] Changes in Financial Disclosure - Starting in 2026, NNIT will refine its financial terminology, changing "revenue growth" to "reported revenue growth" and "organic growth" to "constant currency revenue growth" [2][3] - The company will continue to report on a regional level, splitting Region DK into two areas: "Public" for public service offerings and "SCALES" for Microsoft Dynamics 365 technology offerings [4] Strategic Focus - NNIT sees opportunities for profitable growth in 2026, particularly in the Public segment and lower-tier segments within Life Sciences, despite ongoing geopolitical market unrest [5] - The company aims to strengthen customer relationships and advance its AI agenda across regions [7]